Cornerstone Robotics to Showcase Surgical Robot at Global Health Summit 2026
Cornerstone Robotics will present at the 2nd Global Health Summit in August 2026, where its CEO will deliver a keynote on the evolution of surgical robotics. The company's Sentire surgical system has secured regulatory approvals in China, the EU, and Singapore, and is now used in hospitals across Asia-Pacific and Europe.
Hong Kong-based Cornerstone Robotics will present at the 2nd Global Health Summit (GHS 2026) on August 7-8, 2026 at the Hong Kong Convention and Exhibition Centre. The company’s Founder and CEO will deliver a keynote address titled ‘The Future of Surgery: Accessibility, Connectivity, and Physical AI in Robotic Surgery,’ using the flagship Sentire Endoscopic Surgical System as a case study.
The Sentire system has received marketing approval from China’s National Medical Products Administration (NMPA). In the first half of 2026, it also obtained certification under the European Union Medical Device Regulation (CE MDR) and clearance from the Health Sciences Authority (HSA) of Singapore. The system has been deployed in clinical practice at hospitals across Asia-Pacific and Europe.
The keynote will examine how technology accessibility, seamless system connectivity, and digital integration are reshaping surgical robotics. ‘With the rapid advancement of robotics, digital health and artificial intelligence, the future of surgical robotics is entering a new phase – one that goes beyond greater precision to embrace greater accessibility, seamless connectivity and increasingly intelligent systems with advanced perception and learning capabilities,’ the CEO said. ‘These capabilities will transform robots from instruments of execution into intelligent collaborative partners, driving a fundamental shift in how surgery is performed.’
GHS 2026 is jointly organised by the Hong Kong Investment Corporation Limited (HKIC) and New Frontier under the theme ‘Exponential Leap – From Breakthrough Discovery to Global Impact.’ The summit will bring together over 1,000 healthcare innovators, investors and policymakers.
Cornerstone Robotics, established and incubated in Hong Kong, operates three global R&D hubs and six business centres worldwide. It has built a 30,000-square-metre manufacturing facility in China. The Sentire system was developed entirely in-house and has completed multi-specialty clinical trials.